From: Assessment of serum Talin-1 in liver cirrhosis and hepatocellular carcinoma
 | Early HCC (n=30) | Late HCC (n=30) | Cirrhotic (n=15) | Control (n=15) | Test of Sig. | p |
---|---|---|---|---|---|---|
Age (years) Mean ± SD | 54.77 ± 9.70 | 56.13 ± 6.77 | 53.87 ± 8.41 | 49.93 ± 11.0 | F=1.683 | 0.177 |
Sex | No. (%) | No. (%) | No. (%) | No. (%) | Â | Â |
 Male | 24 (80) | 26 (86.7) | 10 (66.7) | 8 (53.3) | χ2=6.706 | MCp=0.076 |
 Female | 6 (20) | 4 (13.3) | 5 (33.3) | 7 (46.7) | ||
CHILD score | ||||||
 A | 8 (26.7) | 6 (20.0) | 0 (0.0) |  | χ2=26.030* | MCp<0.001* |
 B | 21 (70.0) | 8 (26.7) | 11 (73.3) |  | ||
 C | 1 (3.3) | 16 (53.3) | 4 (26.7) |  | ||
BCLC score | ||||||
 A | 10 (33.3) | 0 |  |  | χ2=60.000 | MCp<0.001* |
 B | 20 (66.7) | 0 |  |  | ||
 C | 0 | 13 (43.3) |  |  | ||
 D | 0 | 17 (56.7) |  |  | ||
Lab Investigations | ||||||
 Hb (g/dl) | 11.43 ± 1.80 | 11.44 ± 1.88 | 10.57 ± 1.78 | 13.73 ± 1.21 | F=9.380* | <0.001* |
 WBCs (103) | 5.45 ± 2.82 | 7.69 ± 4.13 | 5.57 ± 2.80 | 7.97 ± 1.62 | KWχ2= 13.312* | 0.004* |
 Platelets (103) | 111.43±77.54 | 130.70±93.60 | 87.20 ± 53.46 | 317.0 ± 67.35 | KWχ2=32.619* | <0.001* |
 T. Bilirubin (mg/dl) | 1.55 ± 1.08 | 4.92 ± 6.65 | 2.39 ± 3.05 | 0.49 ± 0.2 5 | KWχ2=39.160* | <0.001* |
 INR | 1.40 ± 0.22 | 1.67 ± 0.40 | 1.54 ± 0.36 |  | F=4.870* | 0.01 |
 S. Albumin (g/dl) | 2.81 ± 0.60 | 2.53 ± 0.91 | 2.40 ± 0.59 | 4.35 ± 0.40 | F=27.315* | <0.001* |
 AFP (ng/ml) | 693.9 ± 2216.8 | 4139.9±21178.5 | 9.89 ± 9.27 | 6.02 ± 2.24 | KWχ2= 16.476* | 0.001* |
 S. Talin-1 (ng/ml) | 6.77±1.72 | 10.63±2.13 | 4.19±1.45 | 1.42 ± 1.37 | F = 102.437* | <0.001* |
 pCon | <0.001* | <0.001* | <0.001* |  |  |  |